Cargando…
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
PURPOSE: Bone metastases (BM) from differentiated thyroid carcinoma (DTC) impact negatively the quality of life and the life expectancy of patients. The aim of the study was (a) to evaluate the overall survival (OS) and prognostic factors of OS and (b) to assess predictive factors of complete BM res...
Autores principales: | Jannin, Arnaud, Lamartina, Livia, Moutarde, Coralie, Djennaoui, Mehdi, Lion, George, Chevalier, Benjamin, Vantyghem, Marie Christine, Deschamps, Frédéric, Hadoux, Julien, Baudin, Eric, Schlumberger, Martin, Leboulleux, Sophie, Do Cao, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165254/ https://www.ncbi.nlm.nih.gov/pubmed/35149914 http://dx.doi.org/10.1007/s00259-022-05697-w |
Ejemplares similares
-
Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022) -
Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall Survival
por: Hescot, Segolene, et al.
Publicado: (2022) -
Differentiated Thyroid Cancer in Children and Adolescents: Long Term Outcome and Risk Factors for Persistent Disease
por: Sapuppo, Giulia, et al.
Publicado: (2021) -
MERAIODE: A Redifferentiation Phase II Trial With Trametinib and Dabrafenib Followed by Radioactive Iodine Administration for Metastatic Radioactive Iodine Refractory Differentiated Thyroid Cancer Patients With a BRAFV600E Mutation (NCT 03244956)
por: Leboulleux, Sophie, et al.
Publicado: (2021) -
Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer
por: Hartl, Dana M., et al.
Publicado: (2020)